butylscopolamine bromide
Term · Oncology and biomedicine · MLC-T-ONC-012174
An orally available bromide salt form of butylscopolamine, a quaternary ammonium derivative of the alkaloid scopolamine, with anticholinergic property. Upon oral administration, hyoscine butylbromide binds to and blocks muscarinic receptors located on postganglionic parasympathetic nerve endings and on smooth muscle cells. This blocks the activity of acetylcholine (Ach) and causes its antispasmodic effect in the gastrointestinal (GI), urinary, uterine, and biliary tracts. This agent may also facilitate radiologic visualization of the GI tract.
| Identifier | MLC-T-ONC-012174 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | buscopan; oral hyoscine butylbromide |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012174",
"term": "butylscopolamine bromide",
"field": "Oncology and biomedicine",
"definition": "An orally available bromide salt form of butylscopolamine, a quaternary ammonium derivative of the alkaloid scopolamine, with anticholinergic property. Upon oral administration, hyoscine butylbromide binds to and blocks muscarinic receptors located on postganglionic parasympathetic nerve endings and on smooth muscle cells. This blocks the activity of acetylcholine (Ach) and causes its antispasmodic effect in the gastrointestinal (GI), urinary, uterine, and biliary tracts. This agent may also facilitate radiologic visualization of the GI tract.",
"synonyms": [
"buscopan",
"oral hyoscine butylbromide"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/butylscopolamine-bromide/"
}
Record 3,974 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.